Published in J Am Soc Nephrol on June 01, 1999
Specific immunosuppression with inducible Foxp3-transduced polyclonal T cells. PLoS Biol (2008) 1.55
Report card on renal transplantation. CMAJ (2000) 1.39
The immunosuppressive macrolide RAD inhibits growth of human Epstein-Barr virus-transformed B lymphocytes in vitro and in vivo: A potential approach to prevention and treatment of posttransplant lymphoproliferative disorders. Proc Natl Acad Sci U S A (2000) 1.27
Fetal Hemoglobin Inducers from the Natural World: A Novel Approach for Identification of Drugs for the Treatment of {beta}-Thalassemia and Sickle-Cell Anemia. Evid Based Complement Alternat Med (2007) 1.26
The combination of immunosuppression and carrier cells significantly enhances the efficacy of oncolytic poxvirus in the pre-immunized host. Gene Ther (2010) 1.02
Sirolimus, but not the structurally related RAD (everolimus), enhances the negative effects of cyclosporine on mitochondrial metabolism in the rat brain. Br J Pharmacol (2001) 0.98
Alterations in glucose metabolism by cyclosporine in rat brain slices link to oxidative stress: interactions with mTOR inhibitors. Br J Pharmacol (2004) 0.93
Polylactide-glycoli acid and rapamycin coating intraocular lens prevent posterior capsular opacification in rabbit eyes. Graefes Arch Clin Exp Ophthalmol (2008) 0.91
Association of immunosuppressant-induced protein changes in the rat kidney with changes in urine metabolite patterns: a proteo-metabonomic study. J Proteome Res (2010) 0.90
Immunosuppressant neurotoxicity in rat brain models: oxidative stress and cellular metabolism. Chem Res Toxicol (2010) 0.87
Rapamycin inhibits re-endothelialization after percutaneous coronary intervention by impeding the proliferation and migration of endothelial cells and inducing apoptosis of endothelial progenitor cells. Tex Heart Inst J (2010) 0.85
Sirolimus blocks the accumulation of hyaluronan (HA) by arterial smooth muscle cells and reduces monocyte adhesion to the ECM. Atherosclerosis (2006) 0.85
Surgical biology for the clinician: vascular effects of immunosuppression. Can J Surg (2010) 0.84
Impact of commonly used transplant immunosuppressive drugs on human NK cell function is dependent upon stimulation condition. PLoS One (2013) 0.82
Toxicodynamic effects of ciclosporin are reflected by metabolite profiles in the urine of healthy individuals after a single dose. Br J Clin Pharmacol (2010) 0.82
Autophagy: A new therapeutic target for liver fibrosis. World J Hepatol (2015) 0.81
Low-salt diet and cyclosporine nephrotoxicity: changes in kidney cell metabolism. J Proteome Res (2012) 0.79
Mycophenolate mofetil and FK506 have different effects on kidney allograft fibrosis in rats that underwent chronic allograft nephropathy. BMC Nephrol (2012) 0.79
Inorganic nanoporous membranes for immunoisolated cell-based drug delivery. Adv Exp Med Biol (2010) 0.79
Tacrolimus and sirolimus decrease oxidative phosphorylation of isolated rat kidney mitochondria. Br J Pharmacol (2003) 0.79
Pancreatitis and duodenitis from sarcoidosis: successful therapy with mycophenolate mofetil. Dig Dis Sci (2003) 0.79
Effects of immunosuppression on circulating adeno-associated virus capsid-specific T cells in humans. Hum Gene Ther (2013) 0.78
Effects of oral tacrolimus as a rapid induction therapy in ulcerative colitis. World J Gastroenterol (2015) 0.78
The effect of tacrolimus (FK-506) on Japanese patients with refractory Crohn's disease. J Gastroenterol (2008) 0.78
Membranes to achieve immunoprotection of transplanted islets. Front Biosci (Landmark Ed) (2014) 0.77
BD750, a benzothiazole derivative, inhibits T cell proliferation by affecting the JAK3/STAT5 signalling pathway. Br J Pharmacol (2013) 0.75
The tolerant recipient: looking great in someone else's genes. J Clin Invest (2001) 0.75
Complete remission induced by tacrolimus and low-dose prednisolone in adult minimal change nephrotic syndrome: A pilot study. Kidney Res Clin Pract (2012) 0.75
Rational Design of Benzylidenehydrazinyl-Substituted Thiazole Derivatives as Potent Inhibitors of Human Dihydroorotate Dehydrogenase with in Vivo Anti-arthritic Activity. Sci Rep (2015) 0.75
Beneficial effects of mycophenolate mofetil on cardiotoxicity induced by tacrolimus in wistar rats. Exp Biol Med (Maywood) (2016) 0.75
Clausmarin A, Potential Immunosuppressant Revealed by Yeast-Based Assay and Interleukin-2 Production Assay in Jurkat T Cells. PLoS One (2015) 0.75
Effects of an immunosuppressive treatment on the rat prostate. Drug Des Devel Ther (2016) 0.75
Immunophyllin ligands show differential effects on alcohol self-administration in C57BL mice. J Pharmacol Exp Ther (2012) 0.75
MPA Modulates Tight Junctions' Permeability via Midkine/PI3K Pathway in Caco-2 Cells: A Possible Mechanism of Leak-Flux Diarrhea in Organ Transplanted Patients. Front Physiol (2017) 0.75
Effect of stents coated with a combination of sirolimus and alpha-lipoic acid in a porcine coronary restenosis model. J Mater Sci Mater Med (2016) 0.75
Shigella infection of henle intestinal epithelial cells: role of the host cell. Infect Immun (1979) 5.09
The alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein binds and internalizes Pseudomonas exotoxin A. J Biol Chem (1992) 2.40
Altered surfactant function and structure in SP-A gene targeted mice. Proc Natl Acad Sci U S A (1996) 2.29
Receptor-mediated internalization of Pseudomonas toxin by mouse fibroblasts. Cell (1980) 2.17
The epidemiology of serious eye injuries from the United States Eye Injury Registry. Graefes Arch Clin Exp Ophthalmol (2000) 1.81
Mechanism of action for leflunomide in rheumatoid arthritis. Clin Immunol (1999) 1.72
Mutual transcriptional interference between RelA and androgen receptor. J Biol Chem (1996) 1.60
CHEK2 variants associate with hereditary prostate cancer. Br J Cancer (2003) 1.54
Comparison of the effects of tacrolimus and cyclosporine on the pharmacokinetics of mycophenolic acid. Ther Drug Monit (2001) 1.53
Effects of cyclosporin, FK506, and rapamycin on graft-vessel disease. Lancet (1991) 1.49
In vitro and in vivo activity and cross resistance profiles of novel ruthenium (II) organometallic arene complexes in human ovarian cancer. Br J Cancer (2002) 1.45
The transforming growth factor-betas. A new family of immunoregulatory molecules. Ann N Y Acad Sci (1990) 1.36
Cell cycle protein expression in vascular smooth muscle cells in vitro and in vivo is regulated through phosphatidylinositol 3-kinase and mammalian target of rapamycin. Arterioscler Thromb Vasc Biol (2001) 1.36
Receptor-mediated entry of diphtheria toxin into monkey kidney (Vero) cells: electron microscopic evaluation. Infect Immun (1985) 1.36
Evolving techniques in the treatment of macular detachment caused by optic nerve pits. Ophthalmology (1988) 1.32
AnkB, a periplasmic ankyrin-like protein in Pseudomonas aeruginosa, is required for optimal catalase B (KatB) activity and resistance to hydrogen peroxide. J Bacteriol (2000) 1.31
Molecular mechanisms of action of new xenobiotic immunosuppressive drugs: tacrolimus (FK506), sirolimus (rapamycin), mycophenolate mofetil and leflunomide. Curr Opin Immunol (1996) 1.31
Rapamycin reverses chronic graft vascular disease in a novel cardiac allograft model. Circulation (1999) 1.30
Immunoregulatory role of transforming growth factor beta (TGF-beta) in development of killer cells: comparison of active and latent TGF-beta 1. J Exp Med (1990) 1.28
ELAC2/HPC2 involvement in hereditary and sporadic prostate cancer. Cancer Res (2001) 1.26
Rapamycin inhibits arterial intimal thickening caused by both alloimmune and mechanical injury. Its effect on cellular, growth factor, and cytokine response in injured vessels. Transplantation (1993) 1.22
Globe perforation from peribulbar injection. Arch Ophthalmol (1987) 1.17
Receptor-mediated entry of Pseudomonas toxin: methylamine blocks clustering step. Infect Immun (1983) 1.15
Stanford experience with obliterative bronchiolitis after lung and heart-lung transplantation. Ann Thorac Surg (1996) 1.10
Regulation of the macrophage vacuolar ATPase and phagosome-lysosome fusion by Histoplasma capsulatum. J Immunol (1999) 1.07
Localization of ClC-2 Cl- channels in rabbit gastric mucosa. Am J Physiol Cell Physiol (2001) 1.06
The role of respiratory epithelium in a rat model of obliterative airway disease. Transplantation (2000) 1.06
Comparison of the in vitro metabolism of the macrolide immunosuppressants sirolimus and RAD. Transplant Proc (2001) 1.06
Dominant negative regulation of trans-activation by the rat androgen receptor: roles of the N-terminal domain and heterodimer formation. Mol Endocrinol (1993) 1.05
Vitrectomy in asteroid hyalosis. Retina (1990) 1.05
Dental caries experience of disabled children and young adults in Kuwait. Community Dent Health (2001) 1.04
Therapeutic monitoring of mycophenolic acid. A consensus panel report. Clin Biochem (1998) 1.01
Binding and uptake of pulmonary surfactant protein (SP-A) by pulmonary type II epithelial cells. J Histochem Cytochem (1989) 1.00
Technics for fiberoptic laryngoscopy in anesthesia. Anesth Analg (1974) 1.00
Histoplasma capsulatum yeasts are phagocytosed via very late antigen-5, killed, and processed for antigen presentation by human dendritic cells. J Immunol (2001) 1.00
Reduced temperature alters Pseudomonas exotoxin A entry into the mouse LM cell. Infect Immun (1986) 1.00
Differential effects of glucocorticoid on expression of surfactant proteins in a human lung adenocarcinoma cell line. Biochim Biophys Acta (1988) 0.99
Association of down-regulation of cytokine activity with rat hind limb allograft survival. Transplantation (1995) 0.97
Evidence for pseudomonas exotoxin A receptors on plasma membrane of toxin-sensitive lm fibroblasts. Infect Immun (1984) 0.97
Isolation and characterization of Pseudomonas aeruginosa exotoxin A binding glycoprotein from mouse LM cells. J Biol Chem (1991) 0.96
Normal surfactant pool sizes and inhibition-resistant surfactant from mice that overexpress surfactant protein A. Am J Respir Cell Mol Biol (1999) 0.96
Treatment with rapamycin and mycophenolic acid reduces arterial intimal thickening produced by mechanical injury and allows endothelial replacement. Transplantation (1995) 0.96
Immunosuppressants: cellular and molecular mechanisms of action. Am J Kidney Dis (1996) 0.94
Capturing dynamics with Eiger, a fast-framing X-ray detector. J Synchrotron Radiat (2012) 0.92
Effects of humanized monoclonal antibody to rhesus CD11a in rhesus monkey cardiac allograft recipients. Transplantation (2000) 0.92
Visualization of intracellular trafficking: use of biotinylated ligands in conjunction with avidin-gold colloids. J Histochem Cytochem (1984) 0.92
Ocular self-mutilation. Ann Ophthalmol (1989) 0.92
Essential role of calcium in cellular internalization of Pseudomonas toxin. Infect Immun (1982) 0.91
A novel mechanism of action of the immunomodulatory drug, leflunomide: augmentation of the immunosuppressive cytokine, TGF-beta 1, and suppression of the immunostimulatory cytokine, IL-2. Transplant Proc (1996) 0.90
Immortalization of subpopulations of respiratory epithelial cells from transgenic mice bearing SV40 large T antigen. Am J Physiol (1994) 0.90
Flow cytometric quantitation of calcium-dependent and -independent mitogen-stimulation of T cell functions in whole blood: inhibition by immunosuppressive drugs in vitro. J Immunol Methods (2001) 0.90
Diphtheria toxin does not enter resistant cells by receptor-mediated endocytosis. Infect Immun (1983) 0.90
Leflunomide and malononitriloamides. Expert Opin Investig Drugs (1997) 0.89
Effects of treatment with cyclosporine, FK 506, rapamycin, mycophenolic acid, or deoxyspergualin on vascular muscle proliferation in vitro and in vivo. Transplant Proc (1993) 0.89
Nordic collaborative study of the BARD1 Cys557Ser allele in 3956 patients with cancer: enrichment in familial BRCA1/BRCA2 mutation-negative breast cancer but not in other malignancies. J Med Genet (2006) 0.89
The presence of a transcription activation function in the hormone-binding domain of androgen receptor is revealed by studies in yeast cells. FEBS Lett (1997) 0.89
Pharmacodynamics of immunosuppression by mycophenolic acid: inhibition of both lymphocyte proliferation and activation correlates with pharmacokinetics. J Pharmacol Exp Ther (1999) 0.88
Vascular endothelial growth factor in the rat pituitary: differential distribution and regulation by estrogen. J Endocrinol (2000) 0.88
Prevention of neointimal proliferation by immunosuppression in synthetic vascular grafts. Eur J Cardiothorac Surg (2001) 0.88
Epithelial re-growth is associated with inhibition of obliterative airway disease in orthotopic tracheal allografts in non-immunosuppressed rats. Transplantation (2000) 0.87
Pirfenidone: A novel anti-fibrotic agent and progressive chronic allograft rejection. Pulm Pharmacol Ther (2002) 0.87
Identification of germline MLH1 alterations in familial prostate cancer. Eur J Cancer (2006) 0.87
Indicators for comparing the incidence of diabetic amputations: a nationwide population-based register study. Eur J Vasc Endovasc Surg (2013) 0.86
Graft-versus-host disease prevention by rapamycin: cellular mechanisms. Biol Blood Marrow Transplant (2000) 0.86
Use of nondepolarizing anesthetic agents in penetrating ocular injuries. Anesthesiology (1986) 0.86
Recovery of vision after presumed direct optic nerve injury. Ophthalmology (1987) 0.86
Azurophilic granules of human neutrophils contain CD14. Infect Immun (1997) 0.85
Effect of splenectomy and mono- or combination therapy with rapamycin, the morpholinoethyl ester of mycophenolic acid and deoxyspergualin on cardiac xenograft survival. Transplant Proc (1991) 0.85
Effect of physical training on exercise capacity and gas exchange in patients with chronic heart failure. Chest (1996) 0.85
The therapeutic prescription for the organ transplant recipient: the linkage of immunosuppression and antimicrobial strategies. Transpl Infect Dis (1999) 0.85
T cell subsets required for protection against age-dependent polioencephalomyelitis of C58 mice. J Immunol (1982) 0.85
Inhibition of cellular protein synthesis by vaccinia virus surface tubules. Virology (1982) 0.85
Rapamycin and p53 act on different pathways to induce G1 arrest in mammalian cells. Oncogene (1997) 0.85
Immunosuppressive therapies for the prevention and treatment of obliterative airway disease in heterotopic rat trachea allografts. Transplantation (2000) 0.85
The novel immunosuppressant SDZ-RAD protects rat brain slices from cyclosporine-induced reduction of high-energy phosphates. Br J Pharmacol (2000) 0.85
Endoscopic surgery vs temporary keratoprosthesis vitrectomy. Arch Ophthalmol (1991) 0.85
Comparison of the immunosuppressive and toxic effects of FK506 and cyclosporine in xenograft recipients. Transplant Proc (1989) 0.85
Leflunomide and malononitrilamides. Am J Med Sci (1997) 0.84
A missense substitution A49T in the steroid 5-alpha-reductase gene (SRD5A2) is not associated with prostate cancer in Finland. Br J Cancer (2001) 0.84
Major surgery increases serum levels of vascular endothelial growth factor only temporarily. Am J Surg (2000) 0.84
In vitro and in vivo effects of leflunomide, brequinar, and cyclosporine on pyrimidine biosynthesis. Transplant Proc (1997) 0.84
Problems in the production and use of 5 nm avidin-gold colloids. J Microsc (1986) 0.84
Chronic rejection: the result of uncontrolled remodelling of graft tissue by recipient mesenchymal cells? Data from two rodent models and the effects of immunosuppressive therapies. Inflamm Res (1999) 0.84
Identification and characterization of Magmas, a novel mitochondria-associated protein involved in granulocyte-macrophage colony-stimulating factor signal transduction. Exp Hematol (2001) 0.84
Mechanism of the antiproliferative action of leflunomide. A77 1726, the active metabolite of leflunomide, does not block T-cell receptor-mediated signal transduction but its antiproliferative effects are antagonized by pyrimidine nucleosides. J Heart Lung Transplant (1996) 0.84
Traumatic dural tears: CT diagnosis using metrizamide. Radiology (1984) 0.83
Obliterative bronchiolitis after lung and heart-lung transplantation. Ann Thorac Surg (1995) 0.83
Mycophenolate mofetil: a report of the consensus panel. Ther Drug Monit (1995) 0.83
New vasoconstrictor, bovine peptide B, released during blood coagulation. Nature (1967) 0.83
Eye Injury Registry of Alabama (preliminary report): demographics and prognosis of severe eye injury. South Med J (1987) 0.83
Leflunomide effectively treats naturally occurring immune-mediated and inflammatory diseases of dogs that are unresponsive to conventional therapy. Transplant Proc (1998) 0.83
Feasibility of in vivo intravascular ultrasound tissue characterization in the detection of early vascular transplant rejection. Circulation (1999) 0.82
Adsorption properties of HKUST-1 toward hydrogen and other small molecules monitored by IR. Phys Chem Chem Phys (2007) 0.82
Comparative immunoregulatory effects of rapamycin, FK 506 and cyclosporine on mitogen-induced cytokine production and lymphoproliferation. Transplant Proc (1991) 0.82
Pirfenidone: a novel antifibrotic agent with implications for the treatment of obliterative bronchiolitis. Transplant Proc (1998) 0.82
Variable-temperature microcrystal X-ray diffraction studies of negative thermal expansion in the pure silica zeolite IFR. J Am Chem Soc (2001) 0.82